Skip to main content
Caplight Logo









AilseVax Ltd

AilseVax Ltd

Private
BelfastHealthcare & Life Scienceshttps://ailsebio.com/

Last Round

Seed

May 11, 2023

Total Funding Raised

$1.88M

Company Overview

AilseVax Ltd is a biotechnology company that develops novel cancer vaccine technologies and nanoparticle adjuvants to enhance immune responses.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Application

Keywords

cancer vaccinetherapeutic vaccinecancer immunotherapyantigen discoverynanoparticle adjuvantimmunotherapyoff-the-shelf vaccinecomputational biologydrug discoveryvaccine platformfunctional genomicsin silico drug discoveryneoantigenbiotech startupai drug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AilseVax Ltd Comparables

Compare AilseVax Ltd with similar companies based on industry and business-model similarity.

AilseVax Ltd comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ErVimmune
83%
Infinitopes Precision Immunomics
78%
Nykode Therapeutics
72%

AilseVax Ltd Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMay 11, 2023

AilseVax Ltd Investors

Notable investors and investment history

AilseVax Ltd investors
InvestorRounds
QUBISSeed
Sapphire Capital PartnersSeed
Clarendon Fund ManagersSeed
Techstart VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 14, 2025

    Grew 43% QoQ from 7 to 10 employees.

  • May 11, 2023

    $1.88M raised from co-fund-ni, QUBIS, and others.

AilseVax Ltd Filings

Explore SEC and related filing metadata, where available.

AilseVax Ltd filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about AilseVax Ltd's valuation, stock price, and market status.

Is AilseVax Ltd a public or private company?

AilseVax Ltd is a private company.

What is the current stock price of AilseVax Ltd?

AilseVax Ltd is a private company with no public stock price. No recent secondary market data is available.

How much is AilseVax Ltd worth (valuation)?

Valuation information for AilseVax Ltd is not publicly available.

Can I buy AilseVax Ltd stock?

AilseVax Ltd shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was AilseVax Ltd's last funding round?

AilseVax Ltd's most recent funding round was Seed on May 11, 2023.

Who are the main investors in AilseVax Ltd?

Key investors in AilseVax Ltd include QUBIS, Sapphire Capital Partners, Clarendon Fund Managers, Techstart Ventures.

Will AilseVax Ltd IPO soon?

No public IPO plans have been announced for AilseVax Ltd.

How can I track AilseVax Ltd secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AilseVax Ltd's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBelfast
Employee Range8
Year Founded2021
Last FundingMay 11, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?